BEL, Inc. is a deep-tech company specializing in materials science and surface engineering, focusing on the development and social implementation of advanced functional surfaces with antibacterial, antiviral, and anti-biofilm properties. The company integrates polymer science, additive manufacturing (3D printing), and surface microstructure control to create next-generation functional coatings for applications in medical devices, infrastructure, environmental systems, and marine environments. BEL actively promotes international collaboration with universities, research institutes, and industrial partners, aiming to advance materials innovation by integrating materials science with digital technologies such as data science and digital twin methodologies.
A startup developing and manufacturing reusable high-performance masking films through proprietary fine-particle dispersion technology. By improving efficiency in coating processes and reducing waste, it contributes to lower environmental impact and resource circularity in manufacturing.
We offer technology licensing to various companies for a "perfect alcohol-based sanitizer" effective against food poisoning bacteria that are resistant to standard alcohol sanitizers. The reason these bacteria survive even at 100℃ is their ability to synthesize a robust structure called a spore. We have discovered that substance Y inhibits spore formation, and by incorporating it into alcohol-based sanitizers sterilization becomes possible. Furthermore, substance Y is safe and secure; when added to food products, the bacteria can be killed by heating at 100℃. We are therefore also proposing a new sterilization method.
Solaris Bio revolutionizes regenerative medicine by integrating proprietary Animal-Origin-Free (AOF) formulation designs with advanced cell protection expertise. Centered on our "Organic Solvent-Free Cryopreservation Solution," which boasts the highest safety standards, we offer comprehensive cell manufacturing solutions, including world-class growth media. Leveraging innovative R&D and quality verified by the Certificate of Material Eligibility, we simultaneously enhance cell product efficacy and reduce costs, powerfully accelerating the social implementation of next-generation healthcare.
A startup overcoming challenges in exosome purification with proprietary high-purity, high-yield technology, offering end-to-end support from research to manufacturing. It accelerates practical applications in drug discovery, contributing to a new foundation for pharmaceutical development and driving medical innovation.
